The question of familial meningiomas and schwannomas:
NF2B or not to be?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Meningiomas and schwannomas are common CNS neoplasms, but patients harboring multiple meningiomas or schwannomas are rare. The finding of family members also with multiple meningiomas or schwannomas suggests an inherited cancer predisposition syndrome, such as neurofibromatosis 2 (NF2). In the patient without a family history or insufficient criteria for NF2, the diagnosis of schwannomatosis or meningiomatosis may be entertained. Because it is unclear whether these conditions are distinct clinical entities or represent variants of NF2 (i.e., “NF2A” or “NF2B”),1 Antinheimo et al. undertook a careful analysis of the frequency of meningiomatosis and schwannomatosis in a well-defined population.2 Their results provide important information regarding the evaluation of patients presenting with these common CNS tumors.
In their study, the incidence and familial association of meningiomatosis and schwannomatosis were estimated and the relationship to NF2 was determined.2 Patients derived from a large catchment area of 1.7 million people listed in two reliable population and cancer registries in Finland. The authors determined that isolated schwannomatosis (2% of cases) or meningiomatosis (4% of cases) was rare in patients without clinical or radiographic evidence of NF2. Because it was not clear whether …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Emily Gilmore and Dr. Rachel Beekman
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomasJ. Antinheimo, R. Sankila, O. Carpén et al.Neurology, January 11, 2000 -
Views & Reviews
Diagnostic criteria for schwannomatosisM. MacCollin, E. A. Chiocca, D. G. Evans et al.Neurology, June 13, 2005 -
ARTICLES
SchwannomatosisA clinical and pathologic studyM. MacCollin, W. Woodfin, D. Kronn et al.Neurology, April 01, 1996 -
Article
Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosisMiriam J. Smith, Naomi L. Bowers, Michael Bulman et al.Neurology, November 16, 2016